HCA Healthcare, Inc. $HCA Shares Sold by Te Ahumairangi Investment Management Ltd

Te Ahumairangi Investment Management Ltd trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 28.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,641 shares of the company’s stock after selling 5,505 shares during the period. Te Ahumairangi Investment Management Ltd’s holdings in HCA Healthcare were worth $5,814,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Clearstead Trust LLC increased its holdings in shares of HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. increased its holdings in HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares in the last quarter. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $40,000. Compound Global Advisors LLC purchased a new position in HCA Healthcare in the 3rd quarter valued at approximately $44,000. Finally, True Wealth Design LLC grew its holdings in HCA Healthcare by 179.5% in the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after purchasing an additional 70 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares in the company, valued at $22,411,395. This trade represents a 8.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. Company insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Argus upped their price target on shares of HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a report on Friday, February 6th. Wall Street Zen downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. Leerink Partners raised their price target on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Finally, Mizuho increased their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $537.73.

HCA Healthcare Price Performance

HCA stock traded up $1.14 during midday trading on Friday, hitting $533.72. The stock had a trading volume of 219,850 shares, compared to its average volume of 1,114,783. HCA Healthcare, Inc. has a 12-month low of $313.21 and a 12-month high of $556.52. The company’s 50-day moving average price is $505.79 and its 200 day moving average price is $468.65. The firm has a market cap of $119.35 billion, a PE ratio of 18.80, a price-to-earnings-growth ratio of 1.65 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the previous year, the business earned $6.22 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is 10.15%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.